Great question — and one that many people in your situation are navigating. Here's what's generally known about treatment for bulky mediastinal DLBCL and PMBCL:
Chemotherapy Regimens
The main options used include:
- R-CHOP — the long-standing standard first-line treatment
- Pola-R-CHP — FDA-approved in 2023, similar to Show Full Answer
Great question — and one that many people in your situation are navigating. Here's what's generally known about treatment for bulky mediastinal DLBCL and PMBCL:
Chemotherapy Regimens
The main options used include:
- R-CHOP — the long-standing standard first-line treatment
- Pola-R-CHP — FDA-approved in 2023, similar to R-CHOP but replaces vincristine with polatuzumab vedotin (Polivy), an antibody-drug conjugate that delivers chemo directly to lymphoma cells. Clinical trials showed lower risks of relapse and death compared to R-CHOP
- R-EPOCH — a more aggressive regimen sometimes used for certain subtypes
Both R-CHOP and Pola-R-CHP are typically given as 6 cycles. Consolidation Radiotherapy for Bulky Disease
Radiation after chemo is a real consideration for bulky mediastinal disease. Key points:
- Radiation is recommended when the largest tumor is over 10 cm (bulky disease)
- For DLBCL, radiation is sometimes considered even when tumors are over 7.5 cm
- PET and CT scan results after chemo cycles heavily influence whether radiation is added
- For PMBCL specifically, radiation is sometimes used to shrink remaining mediastinal mass after chemo
The decision really comes down to how well the lymphoma responded to chemo, based on imaging. It would be really worth raising this directly with your oncologist, as the choice between regimens and whether consolidation radiotherapy is needed is very individual — based on tumor size, location, and treatment response.
Other MyLymphomaTeam members dealing with bulky mediastinal lymphoma have shared similar questions, so you're definitely not alone in trying to piece this together. 💙
June 15
Join
Your Privacy Choices
